Bayer logo

Bayer

Last updated January 31, 2026
432
Innovation Areas
13,147
Inventors
104
Collaborations

Radionuclide impurity contamination: BayerRecent Research Landscape

Low binding affinity and rapid clearance of monomeric ligands limit diagnostic sensitivity and therapeutic efficacy. Multimeric chelating structures increase avidity and retention at target sites to overcome poor signal-to-noise ratios.